Company · CIK 0001574094 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
RenovoRx, Inc. · RNXT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 AForm 4 → | Sep 15, 6:04 am EDT | Mark VollChief Financial Officer | 80,000 | — | — | 222,380 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.